Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Jul 6, 2020 8:12 PM EDT Latest News July 4, 2020 New Findings on Gilead’s Biktarvy® Presented at AIDS 2020: Virtual Include Positive Switch Data in Older Adults July 4, 2020 Gilead Sciences Presents Data Supporting a Potential Six-Month Dosing Interval for Investigational HIV-1 Capsid Inhibitor Lenacapavir (GS-6207) July 3, 2020 European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury® (remdesivir) for the Treatment of COVID-19 View All Events May 6, 2020 at 10:00 AM PDT Gilead Sciences 2020 Stockholders Meeting Apr 30, 2020 at 4:30 PM EDT First Quarter 2020 Gilead Sciences Earnings Conference Call Mar 2, 2020 at 12:00 PM EST Gilead Sciences at the Cowen 40th Annual Health Care Conference View All
